Cheaper Genetic Tests for Breast Cancer Risks in 2014?

by jeeg 1. January 2014 20:53
Following the Supreme Court’s rejection of gene patents, the U.S. proposes steep cuts to reimbursements for breast cancer-gene tests.     That natural human genes cannot be patented was one of the biggest biotechnology stories of 2013 and the effects of that Supreme Court decisi... [More]

Why the Angelina Effect Is at Odds With New Guidelines

by jeeg 27. December 2013 02:49
  It's official. The "Angelina Effect" that prompted many women to undergo genetic testing for the breast cancer gene isn't always such a good thing. Actress Angelina Jolie shocked the world last May when she revealed that she'd undergone a preventive double mastectomy after learning th... [More]

In Israel, a Push to Screen for Cancer Gene Leaves Many Conflicted

by jeeg 16. December 2013 21:58
Ever since she tested positive for a defective gene that causes breast cancer, Tamar Modiano has harbored a mother’s fear: that she had passed it on to her two daughters. Ms. Modiano had her breasts removed at 47 to prevent the disease and said that the day she found out her older daught... [More]

Weighing Surgeries in Light of a Breast Cancer Gene

by jeeg 9. October 2013 01:08
When Tracy Dunbrook, a bioethicist in Sherman, Conn., tested positive for the BRCA gene mutation, she was told she had a 40 to 60 percent chance of developing ovarian cancer in her lifetime. Doctors advised her to have her ovaries removed. She considered going further and having a hysterectom... [More]

The Supreme Court's Gene Patenting Decision Was Personal

by jeeg 21. June 2013 18:45
The United States Supreme Court recently ruled that human genes cannot be patented, and this is exciting news for cancer patients, and individuals seeking to learn more about their genetic risk for disease.   The unanimous decision in Association of Molecular Pathology v. Myriad Genetic... [More]

Genetic profiteering: scandal of firm 'hiding vital breast cancer data'

by jeeg 1. November 2012 21:12
The company that makes the world's biggest-selling gene test for breast and ovarian cancers is refusing to share groundbreaking knowledge that could benefit patients, academics claim. Myriad Genetics is accused of deliberately withholding data that could help other scientists to understand cancer g... [More]

Gene patents and democracy

by jeeg 1. April 2011 21:22
On 4 April, the US Court of Appeals for the Federal Circuit in Washington, DC will review a case that calls into question patents on human genes. Much of the debate has focused on how the case might reshape the future of biotechnology research and genomic medicine. But what is at least as impo... [More]

Bid to halt patenting of genes in Australia

by jeeg 8. June 2010 00:02
A landmark court case is set to challenge the legality of an Australian-issued patent for a breast and ovarian cancer gene. If successful, the case could set a precedent leading to other gene patents being overturned. The case could also strengthen calls by researchers, doctors and heal... [More]
Log in